{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T10:30:03Z","timestamp":1762079403686,"version":"build-2065373602"},"reference-count":23,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100016990","name":"Hellenic Society of Cardiology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100016990","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004374","name":"Medtronic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004374","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1016\/j.ahj.2013.07.033","type":"journal-article","created":{"date-parts":[[2013,9,26]],"date-time":"2013-09-26T00:42:27Z","timestamp":1380156147000},"page":"831-838","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Randomized comparison of Zotarolimus-Eluting Endeavor Sprint versus bare-metal stent implantation in uncertain drug-eluting stent candidates: Rationale, design, and characterization of the patient population for the Zotarolimus-eluting Endeavor Sprint stent in Uncertain DES Candidates study"],"prefix":"10.1016","volume":"166","clinical-trial-number":[{"clinical-trial-number":"nct01385319","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Marco","family":"Valgimigli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Athanasios","family":"Patialiakas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Attila","family":"Thury","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salvatore","family":"Colangelo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gianluca","family":"Campo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matteo","family":"Tebaldi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Imre","family":"Ungi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefano","family":"Tondi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Roffi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Menozzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicoletta","family":"de Cesare","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Garbo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emanuele","family":"Meliga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luca","family":"Testa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henrique M.","family":"Gabriel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Flavio","family":"Airoldi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Ferlini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Liistro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Dellavalle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pascal","family":"Vranckx","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlo","family":"Briguori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"15","key":"10.1016\/j.ahj.2013.07.033_bb0005","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1001\/jama.299.15.joc80026","article-title":"Comparison of angioplasty with infusion of tirofiban or abciximab and with implantation of sirolimus-eluting or uncoated stents for acute myocardial infarction: the MULTISTRATEGY randomized trial","volume":"299","author":"Valgimigli","year":"2008","journal-title":"JAMA"},{"issue":"10","key":"10.1016\/j.ahj.2013.07.033_bb0010","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1056\/NEJMoa067484","article-title":"Analysis of 14 trials comparing sirolimus-eluting stents with bare-metal stents","volume":"356","author":"Kastrati","year":"2007","journal-title":"N Engl J Med"},{"issue":"14","key":"10.1016\/j.ahj.2013.07.033_bb0015","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1056\/NEJMoa071076","article-title":"Effectiveness and safety of drug-eluting stents in Ontario","volume":"357","author":"Tu","year":"2007","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.ahj.2013.07.033_bb0020","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.ijcard.2011.07.106","article-title":"Three-year follow-up of the MULTIcentre evaluation of Single high-dose Bolus TiRofiban versus Abciximab with Sirolimus-eluting STEnt or Bare-Metal Stent in Acute Myocardial Infarction StudY (MULTISTRATEGY)","volume":"165","author":"Valgimigli","year":"2013","journal-title":"Int J Cardiol"},{"issue":"3","key":"10.1016\/j.ahj.2013.07.033_bb0025","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.addr.2006.01.021","article-title":"Zotarolimus (ABT-578) eluting stents","volume":"58","author":"Burke","year":"2006","journal-title":"Adv Drug Deliv Rev"},{"issue":"12","key":"10.1016\/j.ahj.2013.07.033_bb0030","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/j.jcin.2010.08.021","article-title":"Long-term clinical outcomes with zotarolimus-eluting versus bare-metal coronary stents","volume":"3","author":"Mauri","year":"2010","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.ahj.2013.07.033_bb0035","doi-asserted-by":"crossref","unstructured":"Camenzind E, Wijns W, Mauri L, et al. Stent thrombosis and major clinical events at 3 years after zotarolimus-eluting or sirolimus-eluting coronary stent implantation: a randomised, multicentre, open-label, controlled trial. Lancet;380(9851):1396\u2013405.","DOI":"10.1016\/S0140-6736(12)61336-1"},{"issue":"5","key":"10.1016\/j.ahj.2013.07.033_bb0065","doi-asserted-by":"crossref","first-page":"562","DOI":"10.4244\/EIJV6I5A95","article-title":"Long-term follow-up of the randomised controlled trial to evaluate the safety and efficacy of the zotarolimus-eluting driver coronary stent in de novo native coronary artery lesions: five year outcomes in the ENDEAVOR II study","volume":"6","author":"Fajadet","year":"2010","journal-title":"EuroIntervention: journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology"},{"issue":"5","key":"10.1016\/j.ahj.2013.07.033_bb0120","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.jcin.2010.12.014","volume":"4","author":"Kandzari","year":"2011","journal-title":"JACC Cardiovasc Interv"},{"issue":"4","key":"10.1016\/j.ahj.2013.07.033_bb0080","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.jcin.2012.12.123","article-title":"The \u201cFinal\u201d 5-year follow-up from the ENDEAVOR IV trial comparing a zotarolimus-eluting stent with a paclitaxel-eluting stent","volume":"6","author":"Kirtane","year":"2013","journal-title":"JACC Cardiovasc Interv"},{"issue":"6","key":"10.1016\/j.ahj.2013.07.033_bb0085","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.jcin.2011.02.017","article-title":"Comparison of titanium-nitride-oxide-coated stents with zotarolimus-eluting stents for coronary revascularization a randomized controlled trial","volume":"4","author":"Pilgrim","year":"2011","journal-title":"JACC Cardiovasc Interv"},{"issue":"9851","key":"10.1016\/j.ahj.2013.07.033_bb0125","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1016\/S0140-6736(12)61336-1","article-title":"Stent thrombosis and major clinical events at 3 years after zotarolimus-eluting or sirolimus-eluting coronary stent implantation: a randomised, multicentre, open-label, controlled trial","volume":"380","author":"Camenzind","year":"2012","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.ahj.2013.07.033_bb0095","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.jcin.2012.04.008","article-title":"3-Year clinical outcomes in the randomized SORT OUT III superiority trial comparing zotarolimus- and sirolimus-eluting coronary stents","volume":"5","author":"Maeng","year":"2012","journal-title":"JACC Cardiovasc Interv"},{"issue":"15","key":"10.1016\/j.ahj.2013.07.033_bb0100","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/j.jacc.2010.03.086","volume":"56","author":"Park","year":"2010","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"10.1016\/j.ahj.2013.07.033_bb0105","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1016\/j.amjcard.2009.06.059","article-title":"Comparison of the efficacy and safety of zotarolimus-, sirolimus-, and paclitaxel-eluting stents in patients with ST-elevation myocardial infarction","volume":"104","author":"Lee","year":"2009","journal-title":"Am J Cardiol"},{"issue":"23","key":"10.1016\/j.ahj.2013.07.033_bb0110","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1016\/j.jacc.2010.03.020","article-title":"2-year clinical and angiographic outcomes from a randomized trial of polymer-free dual drug-eluting stents versus polymer-based Cypher and Endeavor [corrected] drug-eluting stents","volume":"55","author":"Byrne","year":"2010","journal-title":"J Am Coll Cardiol"},{"issue":"15","key":"10.1016\/j.ahj.2013.07.033_bb0045","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1016\/j.jacc.2012.06.043","article-title":"A new strategy for discontinuation of dual antiplatelet therapy: the RESET Trial (REal Safety and Efficacy of 3-month dual antiplatelet Therapy following Endeavor zotarolimus-eluting stent implantation)","volume":"60","author":"Kim","year":"2012","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"10.1016\/j.ahj.2013.07.033_bb0115","doi-asserted-by":"crossref","first-page":"936","DOI":"10.4244\/EIJV7I8A148","volume":"7","author":"Kang","year":"2011","journal-title":"EuroIntervention: journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology"},{"issue":"16","key":"10.1016\/j.ahj.2013.07.033_bb0055","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1161\/CIRCULATIONAHA.111.071589","article-title":"Short- versus long-term duration of dual-antiplatelet therapy after coronary stenting: a randomized multicenter trial","volume":"125","author":"Valgimigli","year":"2012","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.ahj.2013.07.033_bb0040","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/j.jcin.2011.06.017","article-title":"Dual antiplatelet therapy duration and clinical outcomes following treatment with zotarolimus-eluting stents","volume":"4","author":"Kandzari","year":"2011","journal-title":"JACC Cardiovasc Interv"},{"issue":"12","key":"10.1016\/j.ahj.2013.07.033_bb0050","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/j.jcin.2009.10.006","article-title":"Evaluation in 3 months duration of neointimal coverage after zotarolimus-eluting stent implantation by optical coherence tomography: the ENDEAVOR OCT trial","volume":"2","author":"Kim","year":"2009","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.ahj.2013.07.033_bb0060","unstructured":"Valgimigli M, Borghesi M, Tebaldi M,, et al. Should duration of dual antiplatelet therapy depend on the type and\/or potency of implanted stent? A pre-specified analysis from the PROlonging Dual antiplatelet treatment after Grading stent-induced Intimal hyperplasia studY (PRODIGY). Eur Heart J; [Epub ahead of print]."},{"issue":"12","key":"10.1016\/j.ahj.2013.07.033_bb0070","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1093\/eurheartj\/ehs460","article-title":"Should duration of dual antiplatelet therapy depend on the type and\/or potency of implanted stent? A pre-specified analysis from the PROlonging Dual antiplatelet treatment after Grading stent-induced Intimal hyperplasia studY (PRODIGY)","volume":"34","author":"Valgimigli","year":"2013","journal-title":"Eur Heart J"}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870313005358?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870313005358?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T09:55:46Z","timestamp":1762077346000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002870313005358"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11]]},"references-count":23,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["S0002870313005358"],"URL":"https:\/\/doi.org\/10.1016\/j.ahj.2013.07.033","relation":{},"ISSN":["0002-8703"],"issn-type":[{"type":"print","value":"0002-8703"}],"subject":[],"published":{"date-parts":[[2013,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Randomized comparison of Zotarolimus-Eluting Endeavor Sprint versus bare-metal stent implantation in uncertain drug-eluting stent candidates: Rationale, design, and characterization of the patient population for the Zotarolimus-eluting Endeavor Sprint stent in Uncertain DES Candidates study","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahj.2013.07.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}